On February 4, 2021 Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, reported that President and CEO Athena Countouriotis, M.D., will participate in the Guggenheim Healthcare Talks 2021 Oncology Days conference on Feb. 11-12 (Press release, Turning Point Therapeutics, FEB 4, 2021, View Source [SID1234574627]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Countouriotis is scheduled to participate in two question-and-answer sessions: a joint discussion with Zai Lab Founder, Chairperson and CEO Dr. Samantha Du on Feb. 12 at 8:30 a.m. ET, and a company focused discussion at 11:00 a.m. ET, both accessible via webcast through the Investors page of www.tptherapeutics.com.